Menu Search
Equities

Novozymes A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NSIS B:CPH

Novozymes A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)380.90
  • Today's Change3.90 / 1.03%
  • Shares traded148.54k
  • 1 Year change-12.84%
  • Beta0.6009
Data delayed at least 15 minutes, as of May 13 2026 14:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Novozymes A/S grew revenues 8.45% from 3.83bn to 4.16bn while net income improved 90.84% from 305.80m to 583.60m.
Gross margin54.34%
Net profit margin14.21%
Operating margin19.48%
Return on assets3.78%
Return on equity5.39%
Return on investment4.09%
More ▼

Cash flow in EURView more

In 2025, Novozymes A/S did not generate a significant amount of cash. However, the company earned 1.22bn from its operations for a Cash Flow Margin of 29.38%. In addition the company generated 753.30m cash from financing while 1.97bn was spent on investing.
Cash flow per share18.92
Price/Cash flow per share17.67
Book value per share174.94
Tangible book value per share-3.51
More ▼

Balance sheet in EURView more

Novozymes A/S has a Debt to Total Capital ratio of 22.73%, a higher figure than the previous year's 11.30%.
Current ratio1.67
Quick ratio1.03
Total debt/total equity0.2942
Total debt/total capital0.2273
More ▼

Growth rates in EUR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 4.67% and 87.60%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Chemical Manufacturing industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.46%
Div growth rate (5 year)4.32%
Payout ratio (TTM)60.13%
EPS growth(5 years)-1.47
EPS (TTM) vs
TTM 1 year ago		29.82
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.